8-K/A

                        SECURITIES AND EXCHANGE COMMISSION
                            WASHINGTON, D.C. 20549

                                 FORM 8-K/A


                                CURRENT REPORT

                     PURSUANT TO SECTION 13 OR 15(d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934


                   Date of Original Report: February 8, 2000



                         MEDIZONE INTERNATIONAL, INC.
       (Exact name of registrant as specified in its charter)



                    Commission File Number: 2-93277-D

         Nevada                                        87-0412648
(State of Incorporation)                    (I.R.S. Employer Identification No.)


      144 Buena Vista, P.O. Box 742, Stinson Beach, California 94970
             (Address of principal executive offices) (Zip Code)


Registrant's telephone number, including area code:               (415) 868-0300








ITEM 4.   Changes in Registrant's Certifying Accountant.

On January 18, 2000, the Company  appointed Jones Jensen & Co. ("Jones  Jensen")
to replace Andersen & Andersen LLP  ("Andersen") as independent  auditors of the
Company for the fiscal year ending December 31, 1998 and subsequent periods.

The former accountants,  Andersen, were dismissed June 30, 1998. This change was
required  because  Kevin R.  Andersen,  a principal  in  Andersen,  accepted the
position of Chief Financial Officer of the Company in June 1998.

The report of Andersen on the Company's  consolidated  financial  statements for
the years ended  December  31,  1997 and 1996  contained  no adverse  opinion or
disclaimer of opinion and was not qualified or modified as to uncertainty, audit
scope or  accounting  principle,  except  that such  report on the  consolidated
financial  statements  included an  explanatory  paragraph  with  respect to the
Company being in the development stage and its having suffered  recurring losses
which raise substantial doubt about its ability to continue as a going concern.

The decision to engage Jones Jensen as the  Company's  independent  auditors was
approved by the Company's board of directors.

In  connection  with the audits for the years ended  December 31, 1997 and 1996,
and through June 30, 1998, the Company had no disagreements with Andersen on any
matter of accounting principles or practices, financial statement disclosure, or
auditing  scope  or  procedure,  which  disagreements  if  not  resolved  to the
satisfaction  of Andersen would have caused it to make reference  thereto in its
report on the consolidated financial statements for 1997 and 1996.

During the years ended  December  31, 1997 and 1996,  and through June 30, 1998,
there  have been no  reportable  events  (as  defined  in Item  304(a)(1)(v)  of
Regulation S-K).

Andersen has provided to the Company a letter  addressed to the  Securities  and
Exchange Commission stating that it has reviewed the disclosure provided in this
section of this  report on Form 8-K and has no  disagreement  with the  relevant
portions of this  disclosure,  pursuant to the requirements of Item 304(a)(3) of
Regulation  S-K. A copy of such letter,  dated February 29, 2000, is filed as an
Exhibit 16 to this report.

ITEM 7.           Financial Statements and Exhibits.

         (c)      Exhibits

                  16       Letter regarding change in certifying accountant








                                    SIGNATURE

Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned, thereunto duly authorized.

                                      MEDIZONE INTERNATIONAL, INC.
                                      (Registrant)


                                      By:/s/ Edwin G. Marshall
                                      Edwin G. Marshall, Chief Executive Officer

Date: March 1, 2000

EX-16

                                                               February 29, 2000

Securities and Exchange Commission 450 5th Street, N.W.
Washington, D.C. 20549

To Whom It May Concern:

We have been furnished with a copy of the response to Item 4 of the Form 8-K, as
amended,   dated  February  8,  2000,   filed  by  our  former  client  Medizone
International,  Inc. We agree with the statements  made in response to that Item
insofar as they relate to our firm.

Very truly yours,

/s/ Andersen Andersen & Strong, L.C.

Andersen Andersen & Strong, L.C.